Kintara Therapeutics, Inc (KTRA) PT Doubled to $6 at Maxim Group
Tweet Send to a Friend
Maxim Group analyst Jason McCarthy raised the price target on Kintara Therapeutics, Inc (NASDAQ: KTRA) to $6.00 (from $3.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
